Pictet Asset Management (UK)’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-208,729
| Closed | -$2.91M | – | 912 |
|
|
2017
Q4 | $2.91M | Buy |
208,729
+67,700
| +48% | +$944K | 0.01% | 755 |
|
|
2017
Q3 | $2.61M | Sell |
141,029
-14,900
| -10% | -$276K | 0.01% | 761 |
|
|
2017
Q2 | $2.26M | Buy |
155,929
+6,900
| +5% | +$100K | 0.01% | 769 |
|
|
2017
Q1 | $1.99M | Buy |
149,029
+21,100
| +16% | +$282K | 0.01% | 775 |
|
|
2016
Q4 | $1.93M | Sell |
127,929
-106,800
| -45% | -$1.61M | 0.01% | 753 |
|
|
2016
Q3 | $2.74M | Buy |
234,729
+24,800
| +12% | +$290K | 0.01% | 689 |
|
|
2016
Q2 | $2.47M | Buy |
209,929
+18,929
| +10% | +$223K | 0.01% | 720 |
|
|
2016
Q1 | $1.61M | Hold |
191,000
| – | – | 0.01% | 718 |
|
|
2015
Q4 | $2.83M | Sell |
191,000
-53,400
| -22% | -$792K | 0.01% | 670 |
|
|
2015
Q3 | $4.01M | Sell |
244,400
-48,200
| -16% | -$791K | 0.02% | 602 |
|
|
2015
Q2 | $6.36M | Buy |
292,600
+192,437
| +192% | +$4.18M | 0.03% | 532 |
|
|
2015
Q1 | $1.75M | Buy |
100,163
+45,863
| +84% | +$800K | 0.01% | 764 |
|
|
2014
Q4 | $654K | Buy |
54,300
+3,500
| +7% | +$42.2K | ﹤0.01% | 823 |
|
|
2014
Q3 | $576K | Buy |
50,800
+9,900
| +24% | +$112K | ﹤0.01% | 817 |
|
|
2014
Q2 | $494K | Buy |
40,900
+8,300
| +25% | +$100K | ﹤0.01% | 830 |
|
|
2014
Q1 | $380K | Buy |
32,600
+2,500
| +8% | +$29.1K | ﹤0.01% | 829 |
|
|
2013
Q4 | $532K | Sell |
30,100
-12,400
| -29% | -$219K | ﹤0.01% | 812 |
|
|
2013
Q3 | $612K | Buy |
42,500
+5,900
| +16% | +$85K | ﹤0.01% | 800 |
|
|
2013
Q2 | $551K | Buy |
+36,600
| New | +$551K | ﹤0.01% | 798 |
|